Synovial fluid cytokines and eicosanoids as markers of joint disease in horses

Veterinary Surgery

Volumn 30, Issue 6, 2001, Pages 528-538

  Bertone, Alicia L ^a   Palmer, J L ^a   Jones, J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; EQUIDAE; EQUUS CABALLUS; NUCLEOPOLYHEDROVIRUS;

BIOLOGICAL MARKER; CYTOKINE; ICOSANOID; INTERLEUKIN 6; PROSTAGLANDIN E2;

ACUTE DISEASE; ANIMAL; ANIMAL DISEASE; ARTHROPATHY; ARTICLE; CHRONIC DISEASE; HORSE; HORSE DISEASE; METABOLISM; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID; VALIDATION STUDY;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; CHRONIC DISEASE; CYTOKINES; DINOPROSTONE; EICOSANOIDS; HORSE DISEASES; HORSES; INTERLEUKIN-6; JOINT DISEASES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID;

EID: 0035513808     PISSN: 01613499     EISSN: None     Source Type: Journal    
DOI: 10.1053/jvet.2001.28430     Document Type: Article

References (51)

1. Palmer JL, Bertone AL: Joint structure, biochemistry and biochemical disequilibrium in synovitis and equine joint disease. Equine Vet J 26:263-277, 1994
2. Pelletier JP, Roughley PJ, DiBattista JA, et al: Are cytokines involved in osteoarthritic pathophysiology? Semin Arthritis Rheum 20(Suppl)2:12-25, 1991
3. Steinberg JJ, Sledge CB: Chondrocyte mediated cartilage degradation: Regulation by prostaglandin E2, Cyclic AMP and Interferon α. J Rheumatol 18(Suppl)27:63-65, 1991
4. Dayer JM, Seckinger P: Interleukin 1 and interleukin 1 inhibitors and their relation to connective tissue destruction, in Glanert AM (ed). The Control of Tissue Damage. Oxford, England, Elsevier Science, 1988, pp 151-163
5. May SA, Hooke RE, Lees P: Interleukin-1 stimulation of equine articular cells. Res Vet Sci 52:342-348, 1992
6. Saklatvala J: Tumour necrosis factor a stimulated resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547-549, 1986
7. Kandel RA, Petelycky M, Dinarello CA, et al: Comparison of the effect of interleukin 6 and interleukin 1 on collagenase and proteoglycan production by chondrocytes. J Rheumatol 17:953-957, 1990
8. May SA, Hooke RE, Lees P: The characterisation of equine interleukin-1. Vet Immune Immunopath 24:169-175, 1990
9. Morris EA, MacDonald BS, Webb AC, et al: Identification of interleukin-1 in equine osteoarthritic joint effusions. Am J Vet Res 51:59-64, 1990
10. Venn G, Nietfeld JJ, Duits AJ, et al: Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis. Arthritis Rheum 36:819-826,1993
11. Leisten JC, Gaarde WA, Scholz W: Interleukin-6 serum levels correlate with footpad swelling in adjuvant-induced arthritic Lewis rats treated with cyclosporin A or indomethacin. Clin Immunol Immunopathol 56:108-115, 1990
12. Richards CD, Saklatvala J: Molecular cloning and sequence of porcine interleukin 6 cDNA and expression of mRNA in synovial fibroblasts in vitro. Cytokine 3:269-276, 1991
13. Guerne PA, Zuraw BL, Vaughan JH, et al: Synovium as a source of interleukin 6 invitro. J Clin Invest 83:585-592, 1989
14. Wittenberg RH, Willburger RE, Kleemeyer KS, et al: In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum 36:1444-1450, 1993
15. Yoshida K, Kobayashi K, Yamagata N, et al: Inflammatory cytokines and enzymes in synovial fluid patients with rheumatoid arthritis and other arthritides. Int Arch Allergy Immunol 98:286-292, 1992
16. Alwan WH, Carter SD, Dixon JB, et al: Interleukin-1 like activity in synovial fluids and sera of horses with arthritis. Res Vet Sei 51:72-77, 1991
17. Shinmei M, Masuda K, Kikuchi T, et al: Interleukin 1, tumor necrosis factor, and interleukin 6 as mediators of cartilage destruction. Semin Arthritis Rheum 18(Suppl 1):27-32, 1989
18. Hopkins SJ, Humphreys M, Jayson MIV: Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive Il-1. Clin Exp Immunol 72:422-427, 1988
19. Modat G, Dornand J, Bernad N, et al: LPS-stimulated bovine aortic endothelial cells produce IL-1 and IL-6 like activities. Agents Actions 30:403-411,1990
20. Davidson EM, Rae SA, Smith MJH: Leukotriene B4 in synovial fluid. J Pharm Pharmacol 34:410, 1982
21. Higgins AJ, Lees P: Arachidonic acid metabolites in carrageenin-incuded equine inflammatory exudate. J Vet Pharmacol Ther 7:65-72, 1984
22. May SA, Hooke RE, Lees P: Bone fragments stimulate equine synovial lining cells to produce the inflammatory mediator prostaglandin E2. Equine Vet J Suppl 6:131-132, 1992
23. Williams TJ: Prostaglandin E2, prostaglandin 12, and the vascular changes of inflammation Br J Pharmacol 65:517-524, 1979
24. Trang LE, Granstom E, Lovgren O: Levels of prostaglandins F2α and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. Scand J Rheumatol 6:151-154, 1977
25. Hawkins DL, MacKay RJ, Gum GG: Effects of intra-articularly administered endotoxin on clinical signs of disease and synovial fluid tumor necrosis factor, interleukin 6, and prostagandin E2 values in horses. Am J Vet Res 54:379-386, 1993
26. Meyer FA, Yaron L, Taron M: Synergistic, additive, and antagonistic effects of interleukin-1b, tumor necrosis factor α, and γ-interferon on prostaglandin e, hyaluronic acid, and collagenase production by cultured synovial fibroblasts. Arthritis Rheum 33:1518-1525, 1990
27. Martel-Pelletier J, McCollum R, et al: The synthesis of Il-1 receptor antagonist (Il-1ra) by synovial fibroblasts is markedly increased by the cytokines TNF-α and Il-1. Biochim Biophys Acta 1175:302-305, 1993
28. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 265:621-636, 1990
29. Guerne PA, Carson DA, Lotz M: Il-6 production by human articular chondrocytes. J Immunol 144:499-505, 1990
30. Hawkins DL, Cargile JL, MacKay RJ, et al: Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin. Am J Vet Res 56:1292-1297, 1995
31. Cargile JL, MacKay RJ, Dankert JR, et al: Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in miniature horses given endotoxin. Am J Vet Res 56:1445-1450, 1995
32. Cargile JL, MacKay RJ, Dankert JR, et al: Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of miniature horses given endotoxin. Am J Vet Res 56:1451-1459, 1995
33. Platt D: Articular cartilage homeostasis and the role of growth factors and cytokines in regulating matrix composition, in McIlwraith CW, Trotter G (eds). Joint Disease in the Horse. Philadelpha, PA, Saunders, 1996, pp 32-35
34. Ray CS, Poole AR, McIlwraith CW: Use of synovial fluid and serum markers in articular disease, in McIlwraith CW, Trotter G (eds). Joint Disease in the Horse. Philadelphia, PA, Saunders, 1996, pp 207-208
35. Frisbie DD, Ghivizzani S, Robbins PD, et al: Evaluation of equine interleukin-1 receptor antagonist delivered using gene transfer for the treatment of joint disease. Vet Surg 28:393,1999 (abstr)
36. Palmer JL, Bertone AL, McClain: Assessment of glycosaminoglycan concentration in equine synovial fluid as a marker of joint disease. Can J Vet Res 59:205-212, 1995
37. May SA, Hooke RE, Lees P. Equine chondrocyte activation by a variety of stimuli. Br Vet J 148:389-397, 1992
38. Hawkins DL, Cargile JL, MacKay RJ, et al: Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin. Am J Vet Res 56:1292-1299, 1995
39. May SA, Hooke RE, Lees P: Inhibition of interleukin-1 activity by equine synovial fluid. Equine Vet J 24:99-102, 1992
40. MacDonald M, Stover S, Willitis N, et al: Regulation of matrix metabolism in equine cartilage explant cultures by interleukin-1. Am J Vet Res 53:2278-2285, 1992
41. Glew RH. Lipid metabolism II: Pathways of metabolism of special lipids, in Devlin TM (ed). Textbook of Biochemistry (ed 3). New York, NY, Wiley, 1992, pp 462-465
42. Kutukculer N, Caglayan S, Aydogdu F: Study of pro-inflammatory (TNF-alpha, Il-1alpha, Il-6) and T-cell-derived (Il-2, Il-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: Correlations with clinical and laboratory parameters. Clin Rheumatol 17:288-292, 1998
43. Kubota E, Kubota T, Matsumoto J, et al: Synovial fluid cytokinesa and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 56:192-198, 1998
44. Kubota E, Imamura H, Kubota T, et al: Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 55:20-27, 1997
45. Hardy J, Bertone AL, Weisbrode SE, et al: Cell trafficking, mediator release, and articular metabolism in acute inflammation of innervated or denervated isolated equine joints. Am J Vet Res 59:88-100,1998
46. Jeng GW, Wang CR, Liu ST, et al: Measurement of synovial tumor necrosis factor-alpha in diagnosing emergency patients with bacterial arthritis. Am J Emerg Med 15:626-9,1997
47. Vaatainen U, Lohmander LS, Thonar E, et al: Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella. Osteoarthritis Cartilage 6:115-24,1998
48. Murakami KI, Shibata T, Kubota E, et al: Intra-articular levels of prostaglandin E2, hyaluronic acid, and chondroitin-4 and -6 sulfates in the temporomandibular joint synovial fluid of patients with internal derangement. J Oral Maxillofac Surg 56:199-203,1998
49. Howard RD, McIlwraith CW, Trotter GW, et al: Cloning of equine interleukin 1 alpha and equine interleukin 1 beta and determination of their full-length cDNA sequences. Am J Vet Res 59:704-7111, 1998
50. Topper MJ, Prasse KW, Morris MJ: Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses. Am J Vet Res 57:427-431, 1996
51. Topper MJ, Prasse KW: Use of enzyme-linked-immunosorbent assay to measure thrombin-antithrombin III compexes in horses with colic. Am J Vet Res 57:456-462, 1996